Literature DB >> 6616959

Cellular immunity to the hepatitis B virion in acute hepatitis type B.

G Fattovich, A Alberti, C Crivellaro, P Pontisso, F Noventa, G Realdi.   

Abstract

Ten patients were studied serially during acute hepatitis type B for lymphocyte sensitization to the hepatitis B surface antigen (HBsAg) and to the complete hepatitis B virion (Dane particle). Using the lymphocyte transformation test, sensitization to purified HBsAg was not observed during the first 10 days of illness but became detectable later, being particularly evident during convalescence, while sensitization to antigens of the complete virion, other than HBsAg, was demonstrable as soon as at the onset of symptoms, often at the time of maximum liver cell damage. These results indicate that in the course of acute hepatitis type B, lymphocyte sensitization to other antigens of the complete virion precedes that to HBsAg and may be of greater pathogenetic importance.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6616959      PMCID: PMC1535662     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Lack of leukocyte migration inhibition by hepatitis B antigen and normal nonspecific immunoreactivity in asymptomatic carriers.

Authors:  M Desaules; P C Frei; J Libanska; B Wuilleret
Journal:  J Infect Dis       Date:  1976-11       Impact factor: 5.226

2.  Technical study of the leucocyte migration inhibition test in agarose. Application to PPD and to hepatitis B antigen.

Authors:  P Erard
Journal:  Clin Exp Immunol       Date:  1974-11       Impact factor: 4.330

3.  Exposure and immunity to hepatitis-B virus in a liver unit.

Authors:  W D Reed; C G Mitchell; A L Eddleston; W M Lee; R Williams; A J Zuckerman
Journal:  Lancet       Date:  1974-04-06       Impact factor: 79.321

4.  Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

5.  DNA polymerase in the core of the human hepatitis B virus candidate.

Authors:  W S Robinson; R L Greenman
Journal:  J Virol       Date:  1974-06       Impact factor: 5.103

6.  Liver cell surface localization of hepatitis B antigen and of immunoglobulins in acute and chronic hepatitis and in liver cirrhosis.

Authors:  A Alberti; G Realdi; F Tremolada; G P Spina
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

7.  Identification of additional antigenic sites on Dane particles and the tubular forms of hepatitis B surface antigen.

Authors:  A R Neurath; C Trepo; M Chen; A M Prince
Journal:  J Gen Virol       Date:  1976-03       Impact factor: 3.891

8.  Immune response to hepatitis B surface antigen.

Authors:  A B Ibrahim; G N Vyas; H A Perkins
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

9.  Specific lymphocyte stimulation by purified, heat-inactivated hepatitis-B antigen.

Authors:  G C de Gast; B Houwen; H O Nieweg
Journal:  Br Med J       Date:  1973-12-22

10.  Cell-mediated immunity in patients positive for hepatitis-associated antigen.

Authors:  F J Dudley; V Giustino; S Sherlock
Journal:  Br Med J       Date:  1972-12-30
View more
  8 in total

1.  Cell-mediated immunity to hepatitis B virus antigens in mice: correlation of in vivo and in vitro assays.

Authors:  P A De Moerloose; I H Frazer; W A Sewell; E J Collins; I R Mackay
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

2.  Lymphoproliferative disease of granular lymphocytes in a patient with concomitant hepatitis B virus infection of CD4 lymphocytes.

Authors:  C Agostini; R Zambello; P Pontisso; A Alberti; L Trentin; F Siviero; R Foà; F Pandolfi; G Semenzato
Journal:  J Clin Immunol       Date:  1989-09       Impact factor: 8.317

3.  Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.

Authors:  V Barnaba; G Valesini; M Levrero; C Zaccari; A Van Dyke; M Falco; A Musca; F Balsano
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

4.  Large surface proteins of hepatitis B virus containing the pre-s sequence.

Authors:  K H Heermann; U Goldmann; W Schwartz; T Seyffarth; H Baumgarten; W H Gerlich
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

5.  Enhancement by murabutide of the immune response to natural and synthetic hepatitis B surface antigens.

Authors:  F M Audibert; G Przewlocki; C D Leclerc; M E Jolivet; H S Gras-Masse; A L Tartar; L A Chedid
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

6.  Hepatitis B surface antigen specific cytotoxic T lymphocyte activity in hepatitis B virus infection.

Authors:  S Onishi; T Saibara; K Ito
Journal:  Gastroenterol Jpn       Date:  1985-08

7.  Selective sensitization of peripheral blood T lymphocytes to hepatitis B core antigen in patients with chronic active hepatitis type B.

Authors:  C Ferrari; A Penna; P Sansoni; T Giuberti; T M Neri; F V Chisari; F Fiaccadori
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

8.  Delayed type hypersensitivity (DTH) skin reaction to hepatitis B surface antigen (HBsAg) in patients with type B acute and chronic hepatitis.

Authors:  S Nagafuchi; S Kashiwagi; S Hayashi; T Inoue; S Imayama; M Takeshita; M Kikuchi
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.